News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BIOTRONIK SE & Co.KG Expansion Of Promri® Clinical Trial Receives FDA Approval



11/21/2013 10:47:07 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LAKE OSWEGO, Ore.--(BUSINESS WIRE)--BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the U.S. Food and Drug Administration (FDA) has approved an expansion of their ongoing ProMRI® trial. The just-completed Phase A of the trial evaluated the safety of BIOTRONIK’s current pacemaker systems during magnetic resonance imaging (MRI) scans excluding chest and thorax scan areas. Now Phase B of the trial, just approved by the FDA, will evaluate the same pacemaker system during MRI scans without exclusion zones.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES